Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2015

Open Access 01-12-2015 | Research article

Latent class analysis suggests four distinct classes of complementary medicine users among women with breast cancer

Authors: Garrett Strizich, Marilie D. Gammon, Judith S. Jacobson, Melanie Wall, Page Abrahamson, Patrick T. Bradshaw, Mary Beth Terry, Susan Teitelbaum, Alfred I. Neugut, Heather Greenlee

Published in: BMC Complementary Medicine and Therapies | Issue 1/2015

Login to get access

Abstract

Background

Breast cancer patients commonly report using >1 form of complementary and alternative medicine (CAM). However, few studies have attempted to analyze predictors and outcomes of multiple CAM modalities. We sought to group breast cancer patients by clusters of type and intensity of complementary and alternative medicine (CAM) use following diagnosis.

Methods

Detailed CAM use following breast cancer diagnosis was assessed in 2002–2003 among 764 female residents of Long Island, New York diagnosed with breast cancer in 1996–1997. Latent class analysis (LCA) was applied to CAM modalities while taking into account frequency and intensities.

Results

Four distinct latent classes of CAM use emerged: 1) “Low-dose supplement users” (40 %), who used only common nutritional supplements; 2) “Vitamin/mineral supplement users” (39 %), using an abundance of supplements in addition to other practices; 3) “Mind-body medicine users” (12 %), with near-universal use of supplements, mind-body medicine techniques, and massage; and 4) “Multi-modality high-dose users” (9 %), who were highly likely to use nearly all types of CAM. Predictors of membership in classes with substantial CAM use included younger age, more education, higher income, Jewish religion, ideal body mass index, higher fruit and vegetable intake, higher levels of physical activity, receipt of adjuvant chemotherapy, and prior use of oral contraceptives.

Conclusions

LCA identified important subgroups of breast cancer patients characterized by varying degrees of complementary therapy use. Further research should explore the reproducibility of these classes and investigate the association between latent class membership and breast cancer outcomes.
Literature
1.
go back to reference National Center for Complementary and Alternative Medicine. NCCAM third strategic plan: exploring the science of complementary and alternative medicine. Washington, DC: National Center for Complementary and Alternative Medicine; 2011. National Center for Complementary and Alternative Medicine. NCCAM third strategic plan: exploring the science of complementary and alternative medicine. Washington, DC: National Center for Complementary and Alternative Medicine; 2011.
2.
go back to reference Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. 2012;66:924–39.CrossRefPubMed Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. 2012;66:924–39.CrossRefPubMed
3.
go back to reference Yates JS, Mustian KM, Morrow GR, Gillies LJ, Padmanaban D, Atkins JN, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005;13:806–11.CrossRefPubMed Yates JS, Mustian KM, Morrow GR, Gillies LJ, Padmanaban D, Atkins JN, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005;13:806–11.CrossRefPubMed
4.
go back to reference Greenlee H, Kwan MLM, Ergas IIJ, Sherman KJ, Krathwohl SE, Bonnell C, et al. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res. 2009;117:653–65.CrossRef Greenlee H, Kwan MLM, Ergas IIJ, Sherman KJ, Krathwohl SE, Bonnell C, et al. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res. 2009;117:653–65.CrossRef
5.
go back to reference Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007;7:4.CrossRefPubMedPubMedCentral Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007;7:4.CrossRefPubMedPubMedCentral
6.
go back to reference Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD. Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study. Breast Cancer Res Treat. 2006;100:219–27.CrossRefPubMed Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD. Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study. Breast Cancer Res Treat. 2006;100:219–27.CrossRefPubMed
7.
go back to reference Hök J, Tishelman C, Ploner A, Forss A, Falkenberg T. Mapping patterns of complementary and alternative medicine use in cancer: an explorative cross-sectional study of individuals with reported positive “exceptional” experiences. BMC Complement Altern Med. 2008;8:48.CrossRefPubMedPubMedCentral Hök J, Tishelman C, Ploner A, Forss A, Falkenberg T. Mapping patterns of complementary and alternative medicine use in cancer: an explorative cross-sectional study of individuals with reported positive “exceptional” experiences. BMC Complement Altern Med. 2008;8:48.CrossRefPubMedPubMedCentral
8.
go back to reference Ashikaga T, Bosompra K, O’Brien P, Nelson L. Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer. 2002;10:542–8.CrossRefPubMed Ashikaga T, Bosompra K, O’Brien P, Nelson L. Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer. 2002;10:542–8.CrossRefPubMed
9.
go back to reference Carpenter CL, Ganz PA, Bernstein L. Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res Treat. 2009;116:387–96.CrossRefPubMed Carpenter CL, Ganz PA, Bernstein L. Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res Treat. 2009;116:387–96.CrossRefPubMed
10.
go back to reference Greenlee H, Gammon MD, Abrahamson PE, Gaudet MM, Terry MB, Hershman DL, et al. Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the long island breast cancer study project. Cancer. 2009;115:3271–82.CrossRefPubMedPubMedCentral Greenlee H, Gammon MD, Abrahamson PE, Gaudet MM, Terry MB, Hershman DL, et al. Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the long island breast cancer study project. Cancer. 2009;115:3271–82.CrossRefPubMedPubMedCentral
11.
go back to reference Davis SR, Lijovic M, Fradkin P, Bradbury J, La China M, Schwarz M, et al. Use of complementary and alternative therapy by women in the first 2 years after diagnosis and treatment of invasive breast cancer. Menopause. 2010;17:1004–9.CrossRefPubMed Davis SR, Lijovic M, Fradkin P, Bradbury J, La China M, Schwarz M, et al. Use of complementary and alternative therapy by women in the first 2 years after diagnosis and treatment of invasive breast cancer. Menopause. 2010;17:1004–9.CrossRefPubMed
12.
go back to reference Pedersen CG, Christensen S, Jensen AB, Zachariae R. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer. Eur J Cancer. 2009;45:3172–81.CrossRefPubMed Pedersen CG, Christensen S, Jensen AB, Zachariae R. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer. Eur J Cancer. 2009;45:3172–81.CrossRefPubMed
13.
go back to reference Matsuno RK, Pagano IS, Maskarinec G, Issell BF, Gotay CC. Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors. J Womens Health (Larchmt). 2012;21:1252–8.CrossRef Matsuno RK, Pagano IS, Maskarinec G, Issell BF, Gotay CC. Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors. J Womens Health (Larchmt). 2012;21:1252–8.CrossRef
14.
go back to reference Ayers SL, Kronenfeld JJ. Using factor analysis to create complementary and alternative medicine domains: an examination of patterns of use. Health (London). 2010;14:234–52.CrossRef Ayers SL, Kronenfeld JJ. Using factor analysis to create complementary and alternative medicine domains: an examination of patterns of use. Health (London). 2010;14:234–52.CrossRef
15.
go back to reference Neiberg RH, Aickin M, Grzywacz JG, Lang W, Quandt S a, Bell R a, Arcury T a: Occurrence and co-occurrence of types of complementary and alternative medicine use by age, gender, ethnicity, and education among adults in the United States: the. National Health Interview Survey (NHIS). J Altern Complement Med. 2002;2011(17):363–70. Neiberg RH, Aickin M, Grzywacz JG, Lang W, Quandt S a, Bell R a, Arcury T a: Occurrence and co-occurrence of types of complementary and alternative medicine use by age, gender, ethnicity, and education among adults in the United States: the. National Health Interview Survey (NHIS). J Altern Complement Med. 2002;2011(17):363–70.
16.
go back to reference Astin JA, Reilly C, Perkins C, Child WL. Breast cancer patients’ perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen breast cancer foundation. J Soc Integr Oncol. 2006;4:157–69.CrossRefPubMed Astin JA, Reilly C, Perkins C, Child WL. Breast cancer patients’ perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen breast cancer foundation. J Soc Integr Oncol. 2006;4:157–69.CrossRefPubMed
17.
go back to reference Weed DL, Gorelic LS. The practice of causal inference in cancer epidemiology. Cancer Epidemiol Biomarkers Prev. 1996;5:303–11.PubMed Weed DL, Gorelic LS. The practice of causal inference in cancer epidemiology. Cancer Epidemiol Biomarkers Prev. 1996;5:303–11.PubMed
18.
go back to reference Lanza ST, Rhoades BL, Nix RL, Greenberg MT. Modeling the interplay of multilevel risk factors for future academic and behavior problems: a person-centered approach. Dev Psychopathol. 2010;22:313–35.CrossRefPubMedPubMedCentral Lanza ST, Rhoades BL, Nix RL, Greenberg MT. Modeling the interplay of multilevel risk factors for future academic and behavior problems: a person-centered approach. Dev Psychopathol. 2010;22:313–35.CrossRefPubMedPubMedCentral
19.
20.
go back to reference Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, Terry MB, et al. The long island breast cancer study project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat. 2002;74:235–54.CrossRefPubMed Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, Terry MB, et al. The long island breast cancer study project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat. 2002;74:235–54.CrossRefPubMed
21.
go back to reference Cleveland RJ, Eng SM, Abrahamson PE, Britton JA, Teitelbaum SL, Neugut AI, et al. Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1803–11.CrossRefPubMed Cleveland RJ, Eng SM, Abrahamson PE, Britton JA, Teitelbaum SL, Neugut AI, et al. Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1803–11.CrossRefPubMed
22.
go back to reference Charlson M, Pompei P. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J chronic. 1987;40:373–83.CrossRef Charlson M, Pompei P. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J chronic. 1987;40:373–83.CrossRef
23.
go back to reference Schumacker RE, Beyerlein ST. Confirmatory factor analysis with different correlation types and estimation methods. Struct Equ Model. 2000;74:629–36.CrossRef Schumacker RE, Beyerlein ST. Confirmatory factor analysis with different correlation types and estimation methods. Struct Equ Model. 2000;74:629–36.CrossRef
24.
go back to reference Fleming JS. TETCORR: a computer program to compute smoothed tetrachoric correlation matrices. Behav Res Methods. 2005;37:59–64.CrossRefPubMed Fleming JS. TETCORR: a computer program to compute smoothed tetrachoric correlation matrices. Behav Res Methods. 2005;37:59–64.CrossRefPubMed
25.
go back to reference Henson RK. Use of exploratory factor analysis in published research: common errors and some comment on improved practice. Educ Psychol Meas. 2006;66:393–416.CrossRef Henson RK. Use of exploratory factor analysis in published research: common errors and some comment on improved practice. Educ Psychol Meas. 2006;66:393–416.CrossRef
26.
go back to reference Lanza S, Collins L. PROC LCA: A SAS procedure for latent class analysis. Struct Equ. 2007;14(4):671–94.CrossRef Lanza S, Collins L. PROC LCA: A SAS procedure for latent class analysis. Struct Equ. 2007;14(4):671–94.CrossRef
28.
go back to reference Link AR, Gammon MD, Jacobson JS, Abrahamson P, Bradshaw PT, Terry MB, et al. Use of self-care and practitioner-based forms of complementary and alternative medicine before and after a diagnosis of breast cancer. Evid Based Complement Alternat Med. 2013;2013:301549.CrossRefPubMedPubMedCentral Link AR, Gammon MD, Jacobson JS, Abrahamson P, Bradshaw PT, Terry MB, et al. Use of self-care and practitioner-based forms of complementary and alternative medicine before and after a diagnosis of breast cancer. Evid Based Complement Alternat Med. 2013;2013:301549.CrossRefPubMedPubMedCentral
29.
go back to reference Balneaves LG, Bottorff JL, Hislop TG, Herbert C. Levels of commitment: exploring complementary therapy use by women with breast cancer. J Altern Complement Med. 2006;12:459–66.CrossRefPubMed Balneaves LG, Bottorff JL, Hislop TG, Herbert C. Levels of commitment: exploring complementary therapy use by women with breast cancer. J Altern Complement Med. 2006;12:459–66.CrossRefPubMed
30.
go back to reference Wurpts IC, Geiser C. Is adding more indicators to a latent class analysis beneficial or detrimental? Results of a Monte-Carlo study. Front Psychol. 2014;5(August):1–15. Wurpts IC, Geiser C. Is adding more indicators to a latent class analysis beneficial or detrimental? Results of a Monte-Carlo study. Front Psychol. 2014;5(August):1–15.
Metadata
Title
Latent class analysis suggests four distinct classes of complementary medicine users among women with breast cancer
Authors
Garrett Strizich
Marilie D. Gammon
Judith S. Jacobson
Melanie Wall
Page Abrahamson
Patrick T. Bradshaw
Mary Beth Terry
Susan Teitelbaum
Alfred I. Neugut
Heather Greenlee
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2015
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-015-0937-4

Other articles of this Issue 1/2015

BMC Complementary Medicine and Therapies 1/2015 Go to the issue